La. Velloso et al., ABSENCE OF AUTOANTIBODIES AGAINST GLUTAMATE-DECARBOXYLASE (GAD) IN THE NONOBESE DIABETIC (NOD) MOUSE AND LOW EXPRESSION OF THE ENZYME IN MOUSE ISLETS, Clinical and experimental immunology, 96(1), 1994, pp. 129-137
GAD is a major islet cell autoantigen in human type 1 diabetes mellitu
s. Autoantibodies are preferentially directed against the 65-kD isofor
m of the enzyme which is the only form expressed in human islets of La
ngerhans. The NOD mouse is a spontaneous model of type 1 diabetes, fre
quently employed in studies dealing with the immunopathogenesis of the
disease. In the present study the reactivity of sera from 34 prediabe
tic and 15 diabetic NOD mice was tested against GAD protein present in
islets of Langerhans and cerebellum, and against recombinant, semi-pu
rified GAD-65 and GAD-67. A rabbit antiserum (K2) raised against GAD-6
7 could readily recognize the recombinant GAD-67 and the isoform prese
nt in rat and mouse islets and mouse brain. A MoAb (GAD-6) specific fo
r the GAD-65 isoform reacted against the recombinant GAD-65 and the is
oform present in rat islets and mouse brain, whereas no reactivity was
observed when using mouse islets. However, when testing the NOD mice
sera by immunohistochemistry, immunoprecipitation and Western blot, no
reactivity against any of the isoforms of GAD could be detected. Usin
g reverse transcription polymerase chain reaction (PCR), GAD-67 mRNA c
ould be detected in mouse and rat islets and in mouse brain. GAD-65 mR
NA could also be detected in rat islets and mouse brain, but apparentl
y a much lower copy number is present in mouse islets. These findings
stress important differences in the immune response occurring in the a
nimal model NOD mouse compared with human type 1 diabetes, and emphasi
ze that human and animal type 1 diabetes possibly represent the final
outcome of several different etiological factors.